Your browser doesn't support javascript.
loading
Defective Visceral Adipose Tissue Adaptation in Gestational Diabetes Mellitus.
McElwain, Colm J; Manna, Samprikta; Musumeci, Andrea; Sylvester, Isaac; Rouchon, Chloé; O'Callaghan, Anne Marie; Ebad, Mustafa Abdalla Bakhit; McCarthy, Fergus P; McCarthy, Cathal M.
Affiliation
  • McElwain CJ; Department of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
  • Manna S; Department of Obstetrics and Gynaecology, Cork University Maternity Hospital, Cork T12DC4A, Ireland.
  • Musumeci A; Department of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
  • Sylvester I; Department of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
  • Rouchon C; Department of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
  • O'Callaghan AM; Department of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
  • Ebad MAB; Department of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
  • McCarthy FP; Department of Obstetrics and Gynaecology, Cork University Maternity Hospital, Cork T12DC4A, Ireland.
  • McCarthy CM; Department of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
J Clin Endocrinol Metab ; 109(5): 1275-1284, 2024 Apr 19.
Article in En | MEDLINE | ID: mdl-38035802
ABSTRACT
CONTEXT Gestational diabetes mellitus (GDM) is a complex obstetric condition affecting localized glucose metabolism, resulting in systemic metabolic dysfunction.

OBJECTIVE:

This cross-sectional study aimed to explore visceral adipose tissue (VAT) as an integral contributor to GDM, focusing on elucidating the specific contribution of obesity and GDM pathology to maternal outcomes.

METHODS:

Fifty-six nulliparous pregnant women were recruited, including normal glucose tolerant (NGT) (n = 30) and GDM (n = 26) participants. Participants were subgrouped as nonobese (BMI <30 kg/m2) or obese (BMI ≥30 kg/m2). Metabolic markers in circulation, VAT, and placenta were determined. Morphological analysis of VAT and immunoblotting of the insulin signaling cascade were performed.

RESULTS:

GDM participants demonstrated hyperinsulinemia and elevated homeostatic model assessment for insulin resistance (HOMA-IR) scores relative to NGT participants. The GDM-obese subgroup had significant VAT adipocyte hypoplasia relative to NGT-nonobese tissue. GDM-obese VAT had significantly lower insulin receptor substrate (IRS)-2 expression, with elevated ser312 phosphorylation of IRS-1, relative to NGT-nonobese. GDM-obese participants had significantly elevated circulating leptin levels and placental adipsin secretion, while GDM-nonobese participants had elevated circulating adipsin levels with reduced placental adiponectin secretion.

CONCLUSION:

These findings suggest that GDM-obese pregnancy is specifically characterized by inadequate VAT remodeling and dysfunctional molecular signaling, which contribute to insulin resistance and hinder metabolic health.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Endocrinol Metab Year: 2024 Type: Article Affiliation country: Ireland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Endocrinol Metab Year: 2024 Type: Article Affiliation country: Ireland